The components of Other Comprehensive (Loss)/Income were as follows: Year Ended December 31, 2018 2017 2016 Dollars in Millions Pretax Tax After Tax Pretax Tax After Tax Pretax Tax After Tax Derivatives qualifying as cash flow hedges: Unrealized gains/(losses) $ 86 $ (9) $ 77 $ (101) $ 33 $ (68) $ (5) $ — $ (5) Reclassified to net earnings (a) (4 ) (3 ) (7 ) 19 (8 ) 11 12 (3 ) 9 Derivatives qualifying as cash flow hedges 82 (12) 70 (82) 25 (57) 7 (3) 4 Pension and postretirement benefits: Actuarial (losses)/gains (89 ) (3 ) (92 ) 47 11 58 (126 ) (3 ) (129 ) Amortization (b) 65 (13) 52 77 (31) 46 78 (25) 53 Settlements (b) 121 (28 ) 93 167 (57 ) 110 91 (32 ) 59 Pension and postretirement benefits 97 (44) 53 291 (77) 214 43 (60) (17) Available-for-sale securities: Unrealized (losses)/gains (30 ) 5 (25 ) 38 6 44 (12 ) (1 ) (13 ) Realized (gains)/losses (b) — — — (7) 2 (5) 29 — 29 Available-for-sale securities (30 ) 5 (25 ) 31 8 39 17 (1 ) 16 Foreign currency translation (245 ) (9 ) (254 ) (20 ) 38 18 (33 ) (5 ) (38 ) Total Other Comprehensive (Loss)/Income $ (96 ) $ (60 ) $ (156 ) $ 220 $ (6 ) $ 214 $ 34 $ (69 ) $ (35 ) (a) Included in Cost of products sold. (b) Included in Other income (net). The accumulated balances related to each component of Other Comprehensive (Loss)/Income, net of taxes, were as follows: BMS sponsors defined benefit pension plans, defined contribution plans and termination indemnity plans for regular full-time employees. The principal defined benefit pension plan is the Bristol-Myers Squibb Retirement Income Plan (the “Plan”), covering most U.S. employees and representing approximately 66% of the consolidated pension plan assets and 60% of the obligations. Future benefits related to service for this plan were eliminated in 2009. BMS contributes at least the minimum amount required by the ERISA. Plan benefits are based primarily on the participant’s years of credited service and final average compensation. As of December 2018, Plan assets consist primarily of fixed-income securities. In December 2018, BMS announced plans to fully terminate the Bristol-Myers Squibb Retirement Income Plan (the “Plan”). Pension obligations related to the Plan of $3.6 billion will be distributed through a combination of lump sum payments to eligible Plan participants who elect such payments and through the purchase of a group annuity contract from Athene Annuity and Life Company ("Athene"), a wholly-owned insurance subsidiary of Athene Holding Ltd. The benefit obligation for the Plan as of December 31, 2018 was therefore determined on a plan termination basis for which it is assumed that a portion of eligible active and deferred vested participants will elect lump sum payments. The remaining obligation expected to be transferred to Athene includes an annuity purchase price premium. The Plan has sufficient assets to satisfy all transaction obligations. The transaction is expected to close in the third quarter of 2019 at which time the Company expects to record a total non-cash pre-tax pension settlement charge of approximately $1.5 billion to $2.0 billion. December 31, Dollars in Millions 2018 2017 Derivatives qualifying as cash flow hedges $ 51 $ (19 ) Pension and postretirement benefits (2,102) (1,883) Available-for-sale securities (30 ) 32 Foreign currency translation (681) (419) Accumulated other comprehensive loss $ (2,762 ) $ (2,289 ) Note 16. RETIREMENT BENEFITS 90